Ocular Therapeutix (OCUL) Preferred Shares (2013)
Ocular Therapeutix (OCUL) posted quarterly Preferred Shares of $8.5 million for Q4 2013.
Powered by 
Analysis
Ocular Therapeutix (OCUL) Preferred Shares (2013) Analysis & Trends
Ocular Therapeutix has reported Preferred Shares for 1 years, with the latest figure at $8.5 million in Q4 2013.
- Preferred Shares for Q4 2013 came in at $8.5 million, changed N/A year-over-year; the trailing twelve-month figure through Dec 2013 was $8.5 million (changed N/A YoY), and the FY2013 annual result was $8.5 million, down 64.29% from the prior year.
- Preferred Shares held at $8.5 million in Q4 2013.
- Over five years, Preferred Shares peaked at $8.5 million in Q4 2013 and troughed at $8.5 million in Q4 2013.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Preferred Shares (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.78 Bn | 130.92 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.50 Bn | 77.51 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 63.51 Bn | 58.32 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.06 Bn | 52.92 Bn | 52.00 Mn | - |
| 5 | Revolution Medicines | 44.04 Bn | 44.04 Bn | - | - |
| 6 | BeOne Medicines | 40.04 Bn | 34.94 Bn | 1.53 Bn | - |
| 7 | Alnylam Pharmaceuticals | 35.45 Bn | 32.14 Bn | 992.69 Mn | - |
| 8 | Royalty Pharma | 28.41 Bn | 27.57 Bn | - | - |
| 9 | Insmed | 27.42 Bn | 26.26 Bn | 358.27 Mn | - |
| 10 | Ocular Therapeutix | 2.42 Bn | 2.42 Bn | 11.46 Mn | - |